Fulton appoints new management team

Restructures Bristol-based business

Fulton was established in Bristol, UK in 1966 to manufacture vertical tubeless steam boilers. Today the company is part of Fulton Inc, a global manufacturer of steam, hot water and thermal fluid heat transfer systems with production facilities in the UK, US and China.

Following the retirement of the UK firm’s sales and marketing and technical directors, Fulton Inc has restructured the business and appointed Paul Richards as managing director and Carl Knight as UK and European sales and marketing manager.

Richards previously worked for Solatron, while Knight joins Fulton from Spirax Sarco.

Richards said: ‘The changes haven’t just stopped with management appointments. We have also restructured and changed the trading name from Fulton Boiler Works (GB) to Fulton, as we feel it better reflects the business and markets we now operate in.’

Once just a steam boiler manufacturer, Fulton now specialises in the design and manufacture of energy efficient products and ready-to-ship skid mounted and fully packaged boiler plant rooms, he added.

‘We put great emphasis on providing sales and application advice and a full commissioning and after sales service to a growing customer base in hospital and healthcare facilities, food and beverage processing, laundries and other applications.’

Fulton recently introduced of a VMP vertical tubeless boiler, ModSync boiler sequencing system and TDS energy recovery system.

You may also like

Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Manufacturing

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing

Piramal Pharma Solutions announces partnership with Botanix to support drug substance development

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing

ProtaGene and Merck partner to deliver end-to-end biologics testing

The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle
Subscribe now